Extracorporeal life support for refractory ventricular tachycardia

Area of Science:

• Cardiology
• Critical Care Medicine
• Interventional Cardiology

Background:

• Refractory ventricular tachycardia (VT) with cardiogenic shock poses a significant challenge, often unresponsive to standard guidelines.
• Patients in extremis require novel salvage techniques beyond conventional ACC/AHA recommendations.
• Malignant ventricular arrhythmias, cardiac arrest, and pulmonary failure necessitate advanced management strategies.

Purpose of the Study:

• To evaluate the role of Extracorporeal Life Support (ECLS) as a bridging therapy in patients with refractory VT and cardiogenic shock.
• To explore the utility of ECLS in facilitating advanced procedures like VT ablation.
• To assess the effectiveness of ECLS in managing patients with refractory ventricular arrhythmias and cardiopulmonary failure.

Main Methods:

• Literature review using keywords: ECLS, VT, cardiac arrest, VT ablation, venoarterial extra-corporeal membrane oxygenation (VA-ECMO).
• Analysis of case reports describing ECLS use for incessant VT refractory to medical therapy.
• Examination of emergent perfusion strategies and interventions in out-of-hospital VT/VF cases.

Main Results:

• ECLS is indicated for cardiogenic shock from myocardial infarction, myocarditis, drug intoxication, and post-cardiac arrest syndrome.
• ECLS facilitates negative inotropic antiarrhythmic drug therapy and reduces catecholamine dependence, mitigating electric storm.
• ECLS provides hemodynamic stability for VT ablation and early cardiac catheterization access post-cardiac arrest.

Conclusions:

• Current evidence supports ECLS for ensuring vital organ perfusion in refractory VT patients.
• ECLS is a safe, feasible, and effective option when conventional therapies are insufficient for cardiopulmonary support.
• A multidisciplinary team approach is crucial for successful ECLS implementation in complex cardiac cases.